Internal Server Error

About EMBA

EMBA is a venture capital firm founded in 1997. It is primarily based out of Newark on Trent, United Kingdom. As of Oct 2021, EMBA has invested in 5 companies. It primarily invests in Series A round in United Kingdom based startups. Its investments are spread across a wide range of sectors from HealthTech to Life Sciences and High Tech. Most recently it participated in the $***** Seed round of Connected Data Company A lot of funds co-invest with EMBA, with names like E-Synergy sharing a substantial percentage of its portfolio. EMBA has team of 1 people including 1 partners.
Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A & Seed
Portfolio Acquisitions

EMBA's List of All Investments

EMBA has a portfolio of 5 companies. Their most notable investments are in Connected Data Company and Applied Multilayers.Their portfolio spans across and United Kingdom. They have invested in HealthTech, Life Sciences, High Tech and 5 other sectors, across stages such as Series A, Seed stages. Here is the list of all investments by EMBA:
Provider of data-driven debt optimisation services. It connects, optimises, and activates external data to improve business outcomes. This includes managed data services offering accurate addresses, reliable contact details, and enhanced customer insights. The services aim to improve decision-making, collections, and customer engagement by providing access to a wide range of external data sources. The approach facilitates smarter segmentation and complete customer insights, ultimately leading to better results.

Key facts about Connected Data Company

Critical Pharmaceuticals reformulated biologic drugs using proprietary drug delivery technologies. It has two platform technologies: CriticalSorb which is an excipient that enables nasal delivery of existing drugs. and CriticalMix which uses supercritical carbon dixide to enable mixing of drug and polymer for controlled-release formulations. Currently, the company has a nasal growth hormone formulation, nasal Parathyroid Hormone PTH 1-34, long acting growth hormone and long acting risperidone in the pipeline.

Key facts about Critical Pharmaceuticals

  • Founded Year: 2002
  • Location: Nottingham (United Kingdom)
  • Annual Revenue: £0 - £1M as on Dec 31, 2016
  • Stage: Deadpooled
  • Total Funding till date: $2.57M
  • Employee Count: 5 as on Apr 30, 2026
  • Investors: E-Synergy, Catapult Ventures and 3 Others
  • Latest Funding Round: Grant (prize money), May 01, 2015, $*****
Developer of wearable devices for fetal and maternal management. The product uses wireless technologies to facilitate globally accessible obstetric services in the home and hospital. The patented technology is based on the acquisition of electrophysiological signals that can be passively detected by electrodes positioned on the maternal abdomen.

Key facts about Monica Healthcare

Provider of energy efficient building solutions for residential and commercial clients. It is a company specializing in energy efficient building creation and home insulation solutions. They offer a range of services and products to help homeowners and businesses reduce their energy consumption and costs. With a focus on renewable energy and sustainable practices, It aims to provide effective solutions for energy-efficient buildings.

Key facts about Eclipse Energy

  • Founded Year: 2011
  • Location: Halifax (United Kingdom)
  • Stage: Seed
  • Employee Count: 39 as on Aug 31, 2026
  • Investors: EMBA
  • Latest Funding Round: Seed, $*****

Key facts about Applied Multilayers

  • Founded Year: 2003
  • Location: Battle Ground (United States)
  • Stage: Seed
  • Employee Count: 2 as on Aug 31, 2026
  • Investors: EMBA
  • Latest Funding Round: Seed, $*****

EMBA's Investments by Stage

EMBA has made 2 investments in Series A stage with an average round size of $1.17M and 1 investment in Seed stage with an average round size of $826K.
Here are EMBA's investments by stage:
Stage of entry
No. of Investments
Series A
2
Seed
1
Breakdown of EMBA's investments by stage of entrySeries A (2)Seed (1)
Note: We have considered here, only first round of investments

EMBA's Investments by Sector

EMBA has a diverse portfolio, with companies operating in the Life Sciences, Consumer, Enterprise Applications, FinTech and HealthTech. Notably, it has invested in 3 Enterprise (B2B) companies, 3 Tech companies, 1 Consumer (B2C) company and at least 1 company focusing on Social impact.
Here are EMBA's investments by sector:
Sector
No. of Investments
Life Sciences
2
Consumer
1
Enterprise Applications
1
FinTech
1
HealthTech
1
Others
4
Breakdown of EMBA's investments by sectorsLife Sciences (2)Consumer (1)
Note: We have considered here, only first round of investments

EMBA's Investments by Geography

EMBA has made most investments in United Kingdom (3).

EMBA's recent investments

EMBA has not made any investment in 2026 so far.
Here are the most recent investments by EMBA:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Oct 26, 2021
United Kingdom
Seed
5356
-
Jan 30, 2015
United Kingdom
Series A
9038
Jun 27, 2013
United Kingdom
Series A
2789
Feb 23, 2007
United Kingdom
Series A
5881
  [+1]
-
United States
Seed
7022
-

Acquired companies in EMBA's Portfolio

1 company from EMBA's portfolio has been acquired. The most recent acquisition was Monica Healthcare in Mar 2017 by GE HealthCare for $*****.
Here are EMBA's portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Mar 13, 2017
Jun 27, 2013
Series A
5690

Team profile of EMBA

EMBA has a team of 1 member located in United Kingdom. EMBA's team does not sit on the board of any company as of now.

Co-investors of EMBA

Over the past 19 years, 10 investors have co-invested in EMBA's portfolio companies. This includes funds and angels.

Recent News related to EMBA

View all news related to EMBA

FAQs about EMBA

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford